1 Study Coverage
1.1 Endoparasiticide Product Introduction
1.2 Market by Type
1.2.1 Global Endoparasiticide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Ear Tags
1.2.3 Tablets
1.2.4 Injectables
1.2.5 Feed Additives
1.3 Market by Application
1.3.1 Global Endoparasiticide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Veterinary Hospitals or Clinics
1.3.3 Animal Farms
1.3.4 Home Care Settings
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Endoparasiticide Sales Estimates and Forecasts 2017-2028
2.2 Global Endoparasiticide Revenue Estimates and Forecasts 2017-2028
2.3 Global Endoparasiticide Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Endoparasiticide Sales by Region
2.4.1 Global Endoparasiticide Sales by Region (2017-2022)
2.4.2 Global Sales Endoparasiticide by Region (2023-2028)
2.5 Global Endoparasiticide Revenue by Region
2.5.1 Global Endoparasiticide Revenue by Region (2017-2022)
2.5.2 Global Endoparasiticide Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Endoparasiticide Sales by Manufacturers
3.1.1 Global Top Endoparasiticide Manufacturers by Sales (2017-2022)
3.1.2 Global Endoparasiticide Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Endoparasiticide in 2021
3.2 Global Endoparasiticide Revenue by Manufacturers
3.2.1 Global Endoparasiticide Revenue by Manufacturers (2017-2022)
3.2.2 Global Endoparasiticide Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Endoparasiticide Revenue in 2021
3.3 Global Endoparasiticide Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Endoparasiticide Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Endoparasiticide Sales by Type
4.1.1 Global Endoparasiticide Historical Sales by Type (2017-2022)
4.1.2 Global Endoparasiticide Forecasted Sales by Type (2023-2028)
4.1.3 Global Endoparasiticide Sales Market Share by Type (2017-2028)
4.2 Global Endoparasiticide Revenue by Type
4.2.1 Global Endoparasiticide Historical Revenue by Type (2017-2022)
4.2.2 Global Endoparasiticide Forecasted Revenue by Type (2023-2028)
4.2.3 Global Endoparasiticide Revenue Market Share by Type (2017-2028)
4.3 Global Endoparasiticide Price by Type
4.3.1 Global Endoparasiticide Price by Type (2017-2022)
4.3.2 Global Endoparasiticide Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Endoparasiticide Sales by Application
5.1.1 Global Endoparasiticide Historical Sales by Application (2017-2022)
5.1.2 Global Endoparasiticide Forecasted Sales by Application (2023-2028)
5.1.3 Global Endoparasiticide Sales Market Share by Application (2017-2028)
5.2 Global Endoparasiticide Revenue by Application
5.2.1 Global Endoparasiticide Historical Revenue by Application (2017-2022)
5.2.2 Global Endoparasiticide Forecasted Revenue by Application (2023-2028)
5.2.3 Global Endoparasiticide Revenue Market Share by Application (2017-2028)
5.3 Global Endoparasiticide Price by Application
5.3.1 Global Endoparasiticide Price by Application (2017-2022)
5.3.2 Global Endoparasiticide Price Forecast by Application (2023-2028)
6 North America
6.1 North America Endoparasiticide Market Size by Type
6.1.1 North America Endoparasiticide Sales by Type (2017-2028)
6.1.2 North America Endoparasiticide Revenue by Type (2017-2028)
6.2 North America Endoparasiticide Market Size by Application
6.2.1 North America Endoparasiticide Sales by Application (2017-2028)
6.2.2 North America Endoparasiticide Revenue by Application (2017-2028)
6.3 North America Endoparasiticide Market Size by Country
6.3.1 North America Endoparasiticide Sales by Country (2017-2028)
6.3.2 North America Endoparasiticide Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Endoparasiticide Market Size by Type
7.1.1 Europe Endoparasiticide Sales by Type (2017-2028)
7.1.2 Europe Endoparasiticide Revenue by Type (2017-2028)
7.2 Europe Endoparasiticide Market Size by Application
7.2.1 Europe Endoparasiticide Sales by Application (2017-2028)
7.2.2 Europe Endoparasiticide Revenue by Application (2017-2028)
7.3 Europe Endoparasiticide Market Size by Country
7.3.1 Europe Endoparasiticide Sales by Country (2017-2028)
7.3.2 Europe Endoparasiticide Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Endoparasiticide Market Size by Type
8.1.1 Asia Pacific Endoparasiticide Sales by Type (2017-2028)
8.1.2 Asia Pacific Endoparasiticide Revenue by Type (2017-2028)
8.2 Asia Pacific Endoparasiticide Market Size by Application
8.2.1 Asia Pacific Endoparasiticide Sales by Application (2017-2028)
8.2.2 Asia Pacific Endoparasiticide Revenue by Application (2017-2028)
8.3 Asia Pacific Endoparasiticide Market Size by Region
8.3.1 Asia Pacific Endoparasiticide Sales by Region (2017-2028)
8.3.2 Asia Pacific Endoparasiticide Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Endoparasiticide Market Size by Type
9.1.1 Latin America Endoparasiticide Sales by Type (2017-2028)
9.1.2 Latin America Endoparasiticide Revenue by Type (2017-2028)
9.2 Latin America Endoparasiticide Market Size by Application
9.2.1 Latin America Endoparasiticide Sales by Application (2017-2028)
9.2.2 Latin America Endoparasiticide Revenue by Application (2017-2028)
9.3 Latin America Endoparasiticide Market Size by Country
9.3.1 Latin America Endoparasiticide Sales by Country (2017-2028)
9.3.2 Latin America Endoparasiticide Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Endoparasiticide Market Size by Type
10.1.1 Middle East and Africa Endoparasiticide Sales by Type (2017-2028)
10.1.2 Middle East and Africa Endoparasiticide Revenue by Type (2017-2028)
10.2 Middle East and Africa Endoparasiticide Market Size by Application
10.2.1 Middle East and Africa Endoparasiticide Sales by Application (2017-2028)
10.2.2 Middle East and Africa Endoparasiticide Revenue by Application (2017-2028)
10.3 Middle East and Africa Endoparasiticide Market Size by Country
10.3.1 Middle East and Africa Endoparasiticide Sales by Country (2017-2028)
10.3.2 Middle East and Africa Endoparasiticide Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Overview
11.1.3 Boehringer Ingelheim Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Boehringer Ingelheim Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim Recent Developments
11.2 Elanco
11.2.1 Elanco Corporation Information
11.2.2 Elanco Overview
11.2.3 Elanco Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Elanco Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Elanco Recent Developments
11.3 Zoetis
11.3.1 Zoetis Corporation Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Zoetis Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Overview
11.4.3 Merck Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Recent Developments
11.5 Virbac
11.5.1 Virbac Corporation Information
11.5.2 Virbac Overview
11.5.3 Virbac Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Virbac Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Virbac Recent Developments
11.6 Novartis AG
11.6.1 Novartis AG Corporation Information
11.6.2 Novartis AG Overview
11.6.3 Novartis AG Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novartis AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis AG Recent Developments
11.7 Ceva Sante Animlae
11.7.1 Ceva Sante Animlae Corporation Information
11.7.2 Ceva Sante Animlae Overview
11.7.3 Ceva Sante Animlae Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ceva Sante Animlae Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ceva Sante Animlae Recent Developments
11.8 Bayer AG
11.8.1 Bayer AG Corporation Information
11.8.2 Bayer AG Overview
11.8.3 Bayer AG Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bayer AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bayer AG Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 Vetoquinol
11.10.1 Vetoquinol Corporation Information
11.10.2 Vetoquinol Overview
11.10.3 Vetoquinol Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Vetoquinol Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vetoquinol Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Endoparasiticide Industry Chain Analysis
12.2 Endoparasiticide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Endoparasiticide Production Mode & Process
12.4 Endoparasiticide Sales and Marketing
12.4.1 Endoparasiticide Sales Channels
12.4.2 Endoparasiticide Distributors
12.5 Endoparasiticide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Endoparasiticide Industry Trends
13.2 Endoparasiticide Market Drivers
13.3 Endoparasiticide Market Challenges
13.4 Endoparasiticide Market Restraints
14 Key Findings in The Global Endoparasiticide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Endoparasiticide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Ear Tags
Table 3. Major Manufacturers of Tablets
Table 4. Major Manufacturers of Injectables
Table 5. Major Manufacturers of Feed Additives
Table 6. Global Endoparasiticide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Endoparasiticide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Endoparasiticide Sales by Region (2017-2022) & (K Units)
Table 9. Global Endoparasiticide Sales Market Share by Region (2017-2022)
Table 10. Global Endoparasiticide Sales by Region (2023-2028) & (K Units)
Table 11. Global Endoparasiticide Sales Market Share by Region (2023-2028)
Table 12. Global Endoparasiticide Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Endoparasiticide Revenue Market Share by Region (2017-2022)
Table 14. Global Endoparasiticide Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Endoparasiticide Revenue Market Share by Region (2023-2028)
Table 16. Global Endoparasiticide Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Endoparasiticide Sales Share by Manufacturers (2017-2022)
Table 18. Global Endoparasiticide Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Endoparasiticide Revenue Share by Manufacturers (2017-2022)
Table 20. Endoparasiticide Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Endoparasiticide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Endoparasiticide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endoparasiticide as of 2021)
Table 23. Endoparasiticide Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Endoparasiticide Product Offered
Table 25. Date of Manufacturers Enter into Endoparasiticide Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 28. Global Endoparasiticide Sales by Type (2023-2028) & (K Units)
Table 29. Global Endoparasiticide Sales Share by Type (2017-2022)
Table 30. Global Endoparasiticide Sales Share by Type (2023-2028)
Table 31. Global Endoparasiticide Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Endoparasiticide Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Endoparasiticide Revenue Share by Type (2017-2022)
Table 34. Global Endoparasiticide Revenue Share by Type (2023-2028)
Table 35. Endoparasiticide Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Endoparasiticide Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 38. Global Endoparasiticide Sales by Application (2023-2028) & (K Units)
Table 39. Global Endoparasiticide Sales Share by Application (2017-2022)
Table 40. Global Endoparasiticide Sales Share by Application (2023-2028)
Table 41. Global Endoparasiticide Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Endoparasiticide Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Endoparasiticide Revenue Share by Application (2017-2022)
Table 44. Global Endoparasiticide Revenue Share by Application (2023-2028)
Table 45. Endoparasiticide Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Endoparasiticide Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 48. North America Endoparasiticide Sales by Type (2023-2028) & (K Units)
Table 49. North America Endoparasiticide Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Endoparasiticide Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 52. North America Endoparasiticide Sales by Application (2023-2028) & (K Units)
Table 53. North America Endoparasiticide Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Endoparasiticide Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Endoparasiticide Sales by Country (2017-2022) & (K Units)
Table 56. North America Endoparasiticide Sales by Country (2023-2028) & (K Units)
Table 57. North America Endoparasiticide Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Endoparasiticide Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 60. Europe Endoparasiticide Sales by Type (2023-2028) & (K Units)
Table 61. Europe Endoparasiticide Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Endoparasiticide Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 64. Europe Endoparasiticide Sales by Application (2023-2028) & (K Units)
Table 65. Europe Endoparasiticide Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Endoparasiticide Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Endoparasiticide Sales by Country (2017-2022) & (K Units)
Table 68. Europe Endoparasiticide Sales by Country (2023-2028) & (K Units)
Table 69. Europe Endoparasiticide Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Endoparasiticide Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Endoparasiticide Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Endoparasiticide Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Endoparasiticide Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Endoparasiticide Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Endoparasiticide Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Endoparasiticide Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Endoparasiticide Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Endoparasiticide Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Endoparasiticide Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Endoparasiticide Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Endoparasiticide Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Endoparasiticide Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Endoparasiticide Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Endoparasiticide Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Endoparasiticide Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Endoparasiticide Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Endoparasiticide Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Endoparasiticide Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Endoparasiticide Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Endoparasiticide Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Endoparasiticide Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Endoparasiticide Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Endoparasiticide Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Endoparasiticide Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Endoparasiticide Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Endoparasiticide Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Endoparasiticide Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Endoparasiticide Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Endoparasiticide Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Endoparasiticide Revenue by Country (2023-2028) & (US$ Million)
Table 107. Boehringer Ingelheim Corporation Information
Table 108. Boehringer Ingelheim Description and Major Businesses
Table 109. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Boehringer Ingelheim Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Boehringer Ingelheim Recent Developments
Table 112. Elanco Corporation Information
Table 113. Elanco Description and Major Businesses
Table 114. Elanco Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Elanco Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Elanco Recent Developments
Table 117. Zoetis Corporation Information
Table 118. Zoetis Description and Major Businesses
Table 119. Zoetis Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Zoetis Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Zoetis Recent Developments
Table 122. Merck Corporation Information
Table 123. Merck Description and Major Businesses
Table 124. Merck Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Merck Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Merck Recent Developments
Table 127. Virbac Corporation Information
Table 128. Virbac Description and Major Businesses
Table 129. Virbac Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Virbac Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Virbac Recent Developments
Table 132. Novartis AG Corporation Information
Table 133. Novartis AG Description and Major Businesses
Table 134. Novartis AG Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Novartis AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Novartis AG Recent Developments
Table 137. Ceva Sante Animlae Corporation Information
Table 138. Ceva Sante Animlae Description and Major Businesses
Table 139. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Ceva Sante Animlae Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Ceva Sante Animlae Recent Developments
Table 142. Bayer AG Corporation Information
Table 143. Bayer AG Description and Major Businesses
Table 144. Bayer AG Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Bayer AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bayer AG Recent Developments
Table 147. Eli Lilly Corporation Information
Table 148. Eli Lilly Description and Major Businesses
Table 149. Eli Lilly Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Eli Lilly Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Eli Lilly Recent Developments
Table 152. Vetoquinol Corporation Information
Table 153. Vetoquinol Description and Major Businesses
Table 154. Vetoquinol Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Vetoquinol Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Vetoquinol Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Endoparasiticide Distributors List
Table 160. Endoparasiticide Customers List
Table 161. Endoparasiticide Market Trends
Table 162. Endoparasiticide Market Drivers
Table 163. Endoparasiticide Market Challenges
Table 164. Endoparasiticide Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Endoparasiticide Product Picture
Figure 3. Global Endoparasiticide Market Share by Type in 2021 & 2028
Figure 3. Ear Tags Product Picture
Figure 4. Tablets Product Picture
Figure 5. Injectables Product Picture
Figure 6. Feed Additives Product Picture
Figure 7. Global Endoparasiticide Market Share by Application in 2021 & 2028
Figure 8. Veterinary Hospitals or Clinics
Figure 9. Animal Farms
Figure 10. Home Care Settings
Figure 11. Endoparasiticide Report Years Considered
Figure 12. Global Endoparasiticide Sales 2017-2028 (K Units)
Figure 13. Global Endoparasiticide Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Endoparasiticide Revenue 2017-2028 (US$ Million)
Figure 15. Global Endoparasiticide Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Endoparasiticide Sales Market Share by Region (2017-2022)
Figure 17. Global Endoparasiticide Sales Market Share by Region (2023-2028)
Figure 18. North America Endoparasiticide Sales YoY (2017-2028) & (K Units)
Figure 19. North America Endoparasiticide Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Endoparasiticide Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Endoparasiticide Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Endoparasiticide Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Endoparasiticide Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Endoparasiticide Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Endoparasiticide Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Endoparasiticide Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Endoparasiticide Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Endoparasiticide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Endoparasiticide in the World: Market Share by Endoparasiticide Revenue in 2021
Figure 30. Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Endoparasiticide Sales Market Share by Type (2017-2028)
Figure 32. Global Endoparasiticide Revenue Market Share by Type (2017-2028)
Figure 33. Global Endoparasiticide Sales Market Share by Application (2017-2028)
Figure 34. Global Endoparasiticide Revenue Market Share by Application (2017-2028)
Figure 35. North America Endoparasiticide Sales Market Share by Type (2017-2028)
Figure 36. North America Endoparasiticide Revenue Market Share by Type (2017-2028)
Figure 37. North America Endoparasiticide Sales Market Share by Application (2017-2028)
Figure 38. North America Endoparasiticide Revenue Market Share by Application (2017-2028)
Figure 39. North America Endoparasiticide Sales Share by Country (2017-2028)
Figure 40. North America Endoparasiticide Revenue Share by Country (2017-2028)
Figure 41. U.S. Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Endoparasiticide Sales Market Share by Type (2017-2028)
Figure 44. Europe Endoparasiticide Revenue Market Share by Type (2017-2028)
Figure 45. Europe Endoparasiticide Sales Market Share by Application (2017-2028)
Figure 46. Europe Endoparasiticide Revenue Market Share by Application (2017-2028)
Figure 47. Europe Endoparasiticide Sales Share by Country (2017-2028)
Figure 48. Europe Endoparasiticide Revenue Share by Country (2017-2028)
Figure 49. Germany Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 50. France Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Endoparasiticide Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Endoparasiticide Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Endoparasiticide Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Endoparasiticide Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Endoparasiticide Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Endoparasiticide Revenue Share by Region (2017-2028)
Figure 60. China Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 63. India Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Endoparasiticide Sales Market Share by Type (2017-2028)
Figure 71. Latin America Endoparasiticide Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Endoparasiticide Sales Market Share by Application (2017-2028)
Figure 73. Latin America Endoparasiticide Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Endoparasiticide Sales Share by Country (2017-2028)
Figure 75. Latin America Endoparasiticide Revenue Share by Country (2017-2028)
Figure 76. Mexico Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Endoparasiticide Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Endoparasiticide Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Endoparasiticide Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Endoparasiticide Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Endoparasiticide Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Endoparasiticide Revenue Share by Country (2017-2028)
Figure 85. Turkey Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Endoparasiticide Revenue (2017-2028) & (US$ Million)
Figure 88. Endoparasiticide Value Chain
Figure 89. Endoparasiticide Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
